Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
41.38
+0.48 (1.17%)
Jan 21, 2025, 4:00 PM EST - Market closed
Tectonic Therapeutic Employees
Tectonic Therapeutic had 44 employees as of December 31, 2023.
Employees
44
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,215,409
Market Cap
610.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
TECX News
- 16 days ago - Tectonic Therapeutic: Protein Engineering Platform For GPCRs - Seeking Alpha
- 7 weeks ago - Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic: Interesting CV Disease Drug Developer - Seeking Alpha
- 4 months ago - Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewsWire
- 5 months ago - Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewsWire